PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 16, 2025, the company approved non-statutory stock options ...

PTC will demonstrate cloud-native MBD in Onshape with Aura Aero, a leader in sustainable aviation, at Aura Aero's display at ...

Productivity improvements help accelerate design workflows and collaboration Faster composite design and manufacturing while maintaining high precision and quality Advanced simulation and AI ...

PTC Inc. has underperformed its software peers over the past year, and analysts are somewhat optimistic about the stock’s ...

Shares of PTC Inc. PTC shed 2.94% to $167.53 Tuesday, on what proved to be an all-around rough trading session for the stock ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) is one of the 10 biotech stocks screaming a buy. On June 17, analysts at Truist ...

Shares of PTC Inc. PTC advanced 1.93% to $172.61 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.94% to 6,033.11 and the ...

PTC beats earnings estimates but faces a cautious growth outlook amid macroeconomic pressures. Read the key insights on the ...

PTC's SaaS pivot, margin leadership, and valuation discount make it a strong long-term buy for tech-savvy investors in the industrial software space. See more here.

A month has gone by since the last earnings report for PTC Inc. (PTC). Shares have added about 7.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading ...

Investors in PTC Inc (Symbol: PTC) saw new options begin trading today, for the February 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...